Substance P immunoreactivity in Rett syndrome

Citation
K. Deguchi et al., Substance P immunoreactivity in Rett syndrome, PED NEUROL, 22(4), 2000, pp. 259-266
Citations number
28
Categorie Soggetti
Pediatrics,"Medical Research General Topics
Journal title
PEDIATRIC NEUROLOGY
ISSN journal
08878994 → ACNP
Volume
22
Issue
4
Year of publication
2000
Pages
259 - 266
Database
ISI
SICI code
0887-8994(200004)22:4<259:SPIIRS>2.0.ZU;2-H
Abstract
Severe autonomic dysfunction occurs in Rett syndrome (RS), Substance P, a t achykinin peptide that localizes to several brain regions, including the au tonomic nervous system, is reduced in the cerebrospinal fluid of patients w ith RS, The anatomic localization and intensity of substance P immunoreacti vity and glial fibrillary acidic protein-positive astrocytes in the brains of 14 patients with RS were compared with those in the brains of 10 age-mat ched normal patients. Substance P immunoreactivity expression was significa ntly decreased in RS tissue compared with control tissue in the following r egions: dorsal horns, intermediolateral column of the spinal cord, spinal t rigeminal tract, solitary tract and nucleus, parvocellular and pontine reti cular nuclei, and locus ceruleus, A less significant decrease of substance P immunoreactivity occurred in the substantia nigra, central gray of the mi dbrain, frontal cortex, caudate, putamen, globus pallidus, and thalamus, An tiglial fibrillary acidic protein-positive astrocytes were increased in the areas in which substance P immunoreactivity was decreased and in other bra in regions. Because many of the brain regions with the greatest decrease in substance P immunoreactivity are involved in the control of the autonomic nervous system, especially the solitary tracts and reticular formation, red uced substance P may contribute to the autonomic dysfunction in RS. (C) 200 0 by Elsevier Science Inc. All rights reserved.